Prospective Role of Glycosaminoglycans in Apoptosis Associated with Neurodegenerative Disorders

[1]  B. Dudas,et al.  Neurotrophic Effects of the Glycosaminoglycan C3 on Dendritic Arborization and Spines in the Adult Rat Hippocampus: A Quantitative Golgi Study , 2006 .

[2]  B. Dudas,et al.  Low molecular weight glycosaminoglycan C3 attenuates AF64A-stimulated, low-affinity nerve growth factor receptor-immunoreactive axonal varicosities in the rat septum , 2005, Brain Research.

[3]  M. Post,et al.  Abrogation of apoptosis through PDGF-BB-induced sulfated glycosaminoglycan synthesis and secretion. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[4]  B. Huppertz,et al.  Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure. , 2005, American journal of obstetrics and gynecology.

[5]  B. Dudas,et al.  Glycosaminoglycan C3 protects against AF64A-induced cholinotoxicity in a dose-dependent and time-dependent manner , 2004, Brain Research.

[6]  B. Dudas,et al.  Protective effect of the heparin-derived oligosaccharide C3, on AF64A-induced cholinergic lesion in rats , 2003, Neurobiology of Aging.

[7]  L. Espert,et al.  Hyaluronan, a major non‐protein glycosaminoglycan component of the extracellular matrix in human bone marrow, mediates dexamethasone resistance in multiple myeloma , 2003, British journal of haematology.

[8]  B. Dudas,et al.  The blood-brain barrier accessibility of a heparin-derived oligosaccharides C3. , 2002, Thrombosis research.

[9]  B. Dudas,et al.  Oral and subcutaneous administration of the glycosaminoglycan C3 attenuates Aβ(25–35)-induced abnormal tau protein immunoreactivity in rat brain , 2002, Neurobiology of Aging.

[10]  L. Stefanis,et al.  Caspase inhibition: a potential therapeutic strategy in neurological diseases. , 2001, Histology and histopathology.

[11]  N. Cairns,et al.  Expression of apoptosis related proteins in brains of patients with Alzheimer's disease , 2001, Neuroscience Letters.

[12]  N. Cairns,et al.  Alteration of caspases and apoptosis-related proteins in brains of patients with Alzheimer's disease. , 2001, Biochemical and biophysical research communications.

[13]  A. D. Di Giulio,et al.  Glycosaminoglycans in nerve injury: I. Low doses glycosaminoglycans promote neurite formation , 1996, Journal of neuroscience research.

[14]  E. Sigurdsson,et al.  Local and distant histopathological effects of unilateral amyloid-β 25–35 injections into the amygdala of young F344 rats , 1996, Neurobiology of Aging.

[15]  P. Fraser,et al.  Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease , 1995, Nature Medicine.

[16]  J. Wagner,et al.  Sulfated glycosaminoglycans modify growth factor‐induced neurite outgrowth in PC12 cells , 1988, Journal of cellular physiology.

[17]  A. Fisher,et al.  Potential animal models for senile dementia of Alzheimer's type, with emphasis on AF64A-induced cholinotoxicity. , 1986, Annual review of pharmacology and toxicology.